Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:36 PM
Ignite Modification Date:
2025-12-24 @ 3:36 PM
NCT ID:
NCT02143492
Eligibility Criteria:
Inclusion Criteria:
* 1\. Age ≥ 18 years
* 2\. Diagnosis or clinical signs of advanced RCC (Stage III or IV RCC; Refer to Appendix A)
* 3\. Scheduled for cytoreductive or partial (unilateral or bilateral) nephrectomy
* 4\. Signed and dated informed consent document indicating that the subject (or legally acceptable representative) has been informed of all pertinent aspects of tumor specimen collection prior to enrollment
Exclusion Criteria:
* 1\. Evidence of brain metastases prior to nephrectomy
* 2\. Requirement for systemic chronic immunosuppressive drugs or systemic chronic corticosteroids, for active autoimmune disorder(s) or other conditions (e.g.: rheumatoid arthritis, systemic lupus erythematous, multiple sclerosis, organ transplant recipient, etc.)
* 3\. History of HIV infection, or history of chronic infection with Hepatitis B or Hepatitis C
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02143492
Study Brief:
Protocol Section:
NCT02143492